Actively Recruiting
Transnasal Sphenopalatine Ganglion Block for Treatment of Acute Subarachnoid Hemorrhage Associated Headache
Led by University of California, Davis · Updated on 2025-11-26
40
Participants Needed
1
Research Sites
102 weeks
Total Duration
On this page
Sponsors
U
University of California, Davis
Lead Sponsor
A
Agnes Marshall Walker Foundation
Collaborating Sponsor
AI-Summary
What this Trial Is About
The study titled \"Transnasal sphenopalatine ganglion block for treatment of acute subarachnoid hemorrhage associated headache\" is a randomized controlled pilot study aimed at evaluating the efficacy of a transnasal sphenopalatine ganglion (SPG) block in addition to standard pain medication for reducing headache severity in patients with acute subarachnoid hemorrhage (aSAH). The study also examines whether this intervention can reduce opioid requirements during hospitalization and upon discharge.
CONDITIONS
Official Title
Transnasal Sphenopalatine Ganglion Block for Treatment of Acute Subarachnoid Hemorrhage Associated Headache
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Acute subarachnoid hemorrhage
- Age greater than 18 years
- Secured aneurysm
- Ability to verbalize pain score to clinician, nurse, medical translator, or surrogate decision maker
- Patient or surrogate decision maker available to provide consent
You will not qualify if you...
- Age less than 18 years
- Unsecured aneurysm
- Pregnant or lactating
- Prisoner
- Unable to verbalize pain score to clinician, nurse, medical translator, or surrogate decision maker
- Nasal or facial trauma or surgery within the last three months
- Allergy to lidocaine, bupivacaine, or dexamethasone
- Patient unable to consent with no available surrogate decision maker
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UC Davis Medical Center
Sacramento, California, United States, 95817
Actively Recruiting
Research Team
J
Janice Wang-Polagruto, PhD, CCRP
CONTACT
R
Ryan Martin, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here